Adenocarcinoma of the prostate Trials in Detroit, United States
Conditions / Adenocarcinoma of the prostate / Detroit, United States
Adenocarcinoma of the prostate is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02203695 | Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy | COMPLETED | PHASE2 |
| NCT01656304 | Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy | COMPLETED | PHASE2 |
| NCT03535675 | Muscadine Plus (MPX) In Men With Prostate Cancer | TERMINATED | PHASE3 |
| NCT01949337 | Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer | UNKNOWN | PHASE3 |
| NCT00087139 | Ixabepilone in Treating Patients With Metastatic Prostate Cancer | COMPLETED | PHASE2 |
| NCT00337077 | Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | COMPLETED | PHASE2 |
| NCT01270880 | Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | COMPLETED | PHASE2 |
| NCT01468532 | Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT00527124 | Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | TERMINATED | PHASE2 |
| NCT02058706 | LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer | COMPLETED | PHASE2 |